Use of 99m Tc-sestamibi SPECT/CT when conventional imaging studies are negative for localizing suspected recurrence in differentiated thyroid cancer: a method and a lesson for clinical management
Conclusions99mTc-sestamibi may have a role in thyroid cancer localization when physical exam, neck ultrasound, radioiodine scan, chest/abdomen CT, and18F-FDG PET/CT does not identify the source of elevated Tg levels in DTC.
Source: Endocrine - Category: Endocrinology Source Type: research
More News: Cancer | Cancer & Oncology | CT Scan | Lessons | Pathology | PET Scan | SPECT | Study | Thyroid | Thyroid Cancer | Thyroidectomy | Ultrasound